Alliance for Regenerative Medicine Announces CEO Transition

2 years ago

CEO to step down after leading ARM through period of tremendous growth; New Officer Roles AnnouncedWashington, DC, April 27, 2022…

Rakovina Therapeutics Inc. Announces 2021 Financial Results and Provides Corporate Update

2 years ago

VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed…

1Life Healthcare (One Medical) Announces Date of its First Quarter 2022 Results Conference Call

2 years ago

SAN FRANCISCO, April 27, 2022 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that its first…

Allied Corp Announces Initial US$147,000 Purchase Order Continuing into Monthly Supply Agreement for Brazilian Specialty Cancer Care Hospital

2 years ago

KELOWNA, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to…

Vir Biotechnology Announces New Data From the MARCH Hepatitis B Trial, Unveils New Hepatitis D Clinical Program and Highlights Broad Hepatitis Portfolio at Virtual Hepatitis Portfolio R&D Day

2 years ago

– Strategic clinical program for hepatitis B and D with potential for multiple value drivers in 2022 – – Virtual R&D…

Panbela to Host Virtual R&D Day

2 years ago

MINNEAPOLIS, April 27, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics…

T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel

2 years ago

LEXINGTON, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens…

WIMI Hologram Academy: The application of virtual reality technology in balance function disorder after cerebral apoplexy

2 years ago

HONG KONG, April 27, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022

2 years ago

CAMBRIDGE, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare…

BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

2 years ago

ANAHEIM, CA, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of…